COMMUNIQUÉS West-GlobeNewswire

BioStem Technologies to Present at Two Upcoming Investor Conferences
02/09/2025
POMPANO BEACH, Fla., Sept. 02, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for [...]
Outlook Therapeutics Requests Type A Meeting with FDA
02/09/2025
ISELIN, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the standard of care for bevacizumab for the treatment of retina diseases, [...]
Digital Utilities Ventures Accelerates Global Growth with Breakthrough Clean Water and Sustainable Agriculture Technologies
02/09/2025
Company advancing commercialization with new contracts, installations, and manufacturing expansion Modular technologies designed for recurring revenue and scalable international growth Proven blueprint guiding global [...]
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller Capital
02/09/2025
NRx CEO presented plans for HOPE Therapeutics rollout in September 2025 and establishment of flagship location in Palm Beach, FL during symposium presentation with leadership from Rockefeller Capital and Matthew [...]
Silexion Therapeutics to Present at the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
02/09/2025
Grand Cayman, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS- [...]
Predicine Submits First Module of PMA Application to FDA for PredicineCARE™ as a Companion Diagnostic Assay in Bladder Cancer
02/09/2025
HAYWARD, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Predicine, Inc. , a leading molecular insights company, today announced the submission of the first module of its premarket approval (PMA) application to the U.S. Food [...]
Femasys Closes $8 Million in Financing to Accelerate Commercialization of Fertility and Birth Control Portfolios
02/09/2025
--Existing investors, including Femasys’ largest shareholders, reaffirm confidence in Femasys’ strategy for growth and impact in women’s health-- ATLANTA, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), [...]
Windtree Therapeutics Stockholders Approve Key Proposals for Revenue and Profit Generation at the Special Stockholder Meeting
02/09/2025
The Special Stockholder Meeting on August 28, 2025 recorded the proxy voting approvals of all ten of the Windtree proposals by stockholders The stockholder approved proposals provide the foundation for Windtree revenue [...]
Propanc Biopharma Announces Plan to Acquire $100 Million of Ethereum
02/09/2025
Ethereum to Enhance Multi-Faceted Corporate Strategy of Cryptocurrency Exposure, Pharmaceutical Drug Development & Asset Acquisition MELBOURNE, Australia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. ( [...]
Senti Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
02/09/2025
Live webcast presentation with Co-Founder and CEO, Dr. Timothy Lu, on September 8th at 2:00 PM ET SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a [...]
Trinity Biotech Regains Compliance with Nasdaq Listing Requirements
02/09/2025
DUBLIN, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq Global Select: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable [...]
Perfusion Life Approved as GSA Vendor, Enhancing Cardiac Perfusion Staffing for VA Hospitals
02/09/2025
Raleigh, North Carolina, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Perfusion Life , a nationally recognized provider of joint-commission accredited perfusion staffing, has been approved as a vendor on the General Services [...]
Precipio Terminates Its ATM
02/09/2025
Management Decision Further Reinforces Commitment to Responsible Capital Management NEW HAVEN, Conn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , has [...]
Lighthouse Autism Center Affirms Commitment to Nebraska Families Following Medicaid Rate Cuts
02/09/2025
MISHAWAKA, Ind., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lighthouse Autism Center announced today it will continue to provide Applied Behavior Analysis (ABA) therapy to Nebraska families despite a recent 48% reduction in [...]
Military Veterans Join Virtue Recovery to Expand Community Outreach with Hope and Support
02/09/2025
LAS VEGAS, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Virtue Recovery is proud to announce the expansion of its Business Development Team with the addition of two U.S. military veterans: Adam Khosroabadi, U.S. Marine Corps [...]
Dianabol (Dbol) Pills 2025: DBal Max Launch Dianabol Anabolic Legal Steroid Alternatives for Beginners Dosage Usage, Benefits & Results
02/09/2025
Dianabol (D-bol) Pills for Muscle Growth: Read Benefits, Dianabol Side Effects, Results, and advanced Alternatives Pills From D-Bal Max new york, Sept. 02, 2025 (GLOBE NEWSWIRE) -- August 31, 2025 | New York, (Dbal Max [...]
Trading by management and close relations of management
02/09/2025
Please read the announcement in PDF Attachment 2025_43_Trading_By_Management
FibroGen Completes Sale of FibroGen China to AstraZeneca for Approximately $220 Million
02/09/2025
Total consideration for the sale of FibroGen China to AstraZeneca is approximately $220 million, a $60 million increase from initial guidance Successfully repaid term loan to Morgan Stanley Tactical Value, further [...]
Seer Appoints Isaac Ro to its Board of Directors
02/09/2025
REDWOOD CITY, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced it has appointed Isaac Ro to serve on its Board [...]

Pages